Market Overview:
The global mycoplasma diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of mycoplasma infections, rising demand for rapid and accurate diagnosis, and technological advancements in mycoplasma diagnostics. The kits & reagents segment is expected to account for the largest share of the global mycoplasma diagnostics market in 2018. This segment is also projected to grow at a CAGR of 7.8% from 2018 to 2030. The large share of this segment can be attributed to the growing demand for rapid and accurate diagnosis, rising incidence of mycoplasma infections, and technological advancements in mycoplasma diagnostics. The hospitals segment is expected to account for the largest share of the global mycoplasma diagnostics market in 2018.
Product Definition:
Mycoplasma diagnostics is the identification and characterization of Mycoplasma species. It is important for the diagnosis of mycoplasmal infections, which can cause a variety of diseases in humans and other animals.
Kits & Reagents:
Kits & reagents are used for the detection of Mycoplasma. Kits and reagents are an integral part of any laboratory test or diagnostic process. The growth factor in this market is increasing demand for rapid diagnostic tests to be implemented in clinical laboratories, hospitals, and other healthcare settings. This factor is expected to drive the market during the forecast period with growing awareness among people regarding early diagnosis leading to effective treatment procedures.
Instruments:
Instruments and it's usage in mycoplasma diagnostics market is used for the detection of diseases caused by mycoplasma bacteria. These are small, Gram-positive bacteria that are generally found in soil, water or plants. Some species cause disease in humans and animals while others can be beneficial to the host organism by producing antibiotics.
Application Insights:
The others application segment held the largest share of over 70.0% in 2017. The growth can be attributed to the increasing demand for mycoplasma tests from private laboratories, research institutions and government agencies across the globe. Increasing awareness about diseases caused by low mycoplasma contamination levels is also responsible for driving this segment with a significant CAGR during the forecast period.
The hospitals application segment accounted for a substantial share in 2017 due to high prevalence of hospital-acquired infections that are majorly caused by Mycobacterium tuberculosis and MDR pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA). In addition, an increase in healthcare spending along with growing global awareness about early diagnosis is expected to drive this segment significantly over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increasing prevalence of infectious diseases, and high adoption rate for advanced diagnostic technologies. The U.S.
Asia Pacific is expected to grow at a lucrative CAGR during the forecast period due to factors such as improving healthcare facilities and growing awareness regarding early diagnosis coupled with rising disposable income levels amongst people especially patients & their families resulting into higher demand for medical tests leading towards increased revenue generation from mycoplasma diagnostics industry over this region during forecast period.
Growth Factors:
- Increasing incidence of Mycoplasma infections: The global incidence of mycoplasma infections is increasing due to the growing population and their changing lifestyle. This is driving the demand for mycoplasma diagnostics products and services.
- Growing awareness about mycoplasma infections: There is a growing awareness among people about mycoplasma infections and their symptoms, which is driving the demand for mycoplasma diagnostics products and services.
- Technological advancements in Mycoplasma diagnostics: The technological advancements in Mycoplasma diagnostics are helping to improve the accuracy of diagnosis, which is driving the growth of this market.
- Rising number of mergers & acquisitions (M&A) in Mycopalsma Diagnostics market: There has been a significant rise in M&A activities in the Mycopalsma Diagnostics market over the past few years, owing to the growing demand for these products and services worldwide. This is helping to drivethe growth of this market significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mycoplasma Diagnostics Market Research Report
By Type
Kits & Reagents, Instruments, Software & Services
By Application
Hospitals, Diagnostic Laboratories, Clinics, Others
By Companies
Agilent Technologies, Thermo Fisher Scientific, PromoCell, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Bio (Takara Holding Company.), Savyon Diagnostics, Tecan Trading (Tecan Group), Sartorius Stedim BioOutsource, American Type Culture Collection (ATCC), F Hoffmann-La Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Mycoplasma Diagnostics Market Report Segments:
The global Mycoplasma Diagnostics market is segmented on the basis of:
Types
Kits & Reagents, Instruments, Software & Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Laboratories, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Thermo Fisher Scientific
- PromoCell
- Charles River Laboratories International
- Merck KGaA
- Lonza Group
- Takara Bio (Takara Holding Company.)
- Savyon Diagnostics
- Tecan Trading (Tecan Group)
- Sartorius Stedim BioOutsource
- American Type Culture Collection (ATCC)
- F Hoffmann-La Roche
Highlights of The Mycoplasma Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Kits & Reagents
- Instruments
- Software & Services
- By Application:
- Hospitals
- Diagnostic Laboratories
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mycoplasma Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mycoplasma Diagnostics is a company that provides diagnostic testing for Mycoplasma infections. The company offers tests for Mycoplasma pneumoniae, Mycoplasma genitalium, and other types of myco-infections.
Some of the key players operating in the mycoplasma diagnostics market are Agilent Technologies, Thermo Fisher Scientific, PromoCell, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Bio (Takara Holding Company.), Savyon Diagnostics, Tecan Trading (Tecan Group), Sartorius Stedim BioOutsource, American Type Culture Collection (ATCC), F Hoffmann-La Roche.
The mycoplasma diagnostics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mycoplasma Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mycoplasma Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mycoplasma Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mycoplasma Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mycoplasma Diagnostics Market Size & Forecast, 2020-2028
4.5.1 Mycoplasma Diagnostics Market Size and Y-o-Y Growth
4.5.2 Mycoplasma Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Kits & Reagents
5.2.2 Instruments
5.2.3 Software & Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Laboratories
6.2.3 Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mycoplasma Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mycoplasma Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Kits & Reagents
9.6.2 Instruments
9.6.3 Software & Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Laboratories
9.10.3 Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Kits & Reagents
10.6.2 Instruments
10.6.3 Software & Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Laboratories
10.10.3 Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Kits & Reagents
11.6.2 Instruments
11.6.3 Software & Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Laboratories
11.10.3 Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Kits & Reagents
12.6.2 Instruments
12.6.3 Software & Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Laboratories
12.10.3 Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Kits & Reagents
13.6.2 Instruments
13.6.3 Software & Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Laboratories
13.10.3 Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mycoplasma Diagnostics Market: Competitive Dashboard
14.2 Global Mycoplasma Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agilent Technologies
14.3.2 Thermo Fisher Scientific
14.3.3 PromoCell
14.3.4 Charles River Laboratories International
14.3.5 Merck KGaA
14.3.6 Lonza Group
14.3.7 Takara Bio (Takara Holding Company.)
14.3.8 Savyon Diagnostics
14.3.9 Tecan Trading (Tecan Group)
14.3.10 Sartorius Stedim BioOutsource
14.3.11 American Type Culture Collection (ATCC)
14.3.12 F Hoffmann-La Roche
